跳至主要内容
临床试验/CTRI/2024/07/071522
CTRI/2024/07/071522尚未招募2/3 期

A comparative clinical study of the effect of Siravedh and Gudaharitaki in the management of Vatarakta w.s.r. to Gout

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年8月16日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
relief in sign and symptoms of Vatarakta (Gout), decrease level of Uric acid in Blood

研究概览

简要总结

It is a Randomized, Prospective, Open label, Interventional comparative clinical trial. Three groups have been made for the trial in which one of the group will receive Siravedh karma, second group will receive Gud Haritaki and third group will receive siravedha and Guda haritaki togetherly.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients of classical sign and symptoms of Vatarakta (Gout)with serum uric acid level greater than 7mg/dl in males and 6mg/dl in females.
  • Age 16 to 70 years, of either sex.
  • Patients willing to undergo trial.

排除标准

  • Not willing to undergo trial.
  • Patients having other associated arthropathies.
  • Patients taking modern medicines like uricosuric or xanthine oxidase inhibitors.
  • Contraindication of Siravedh.
  • Patients suffering from any bleeding disorders, pregnancy, anemia, uncontrolled diabetes mellitus will be excluded from the study.
  • Existing or less than 2 weeks ago oral treatment with corticosteroids or colchicine.

结局指标

主要结局

relief in sign and symptoms of Vatarakta (Gout), decrease level of Uric acid in Blood

时间窗: 2 months

次要结局

  • relief in sign and symptoms of Vatarakta (Gout), decrease level of Uric acid in Blood(3 months)

研究者

发起方
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Prem Kumar

Postgraduate Institute of Ayurved, Dr.S.R.Rajasthan Ayurved University, Jodhpur

研究点 (1)

Loading locations...

相似试验